Hoolest

Hoolest operates where consumer wellness hardware meets non-invasive neuromodulation, focusing on devices intended to stimulate the vagus nerve for stress management, relaxation, and sleep support. Its offerings cover multiple form factors: the portable VeRelief Prime handheld device, Hoolest Pro headphones with bilateral stimulation, and the Mini-Max PEMF system. This range gives the company a broader hardware proposition than a single-purpose relaxation wearable, while Hoolest Sleep extends the lineup into supplements. Hoolest’s stated differentiators are its dry hydrogel electrode tips, five selectable Prime modes, guided breathing in certain modes, and operation without an app, Bluetooth connection, or conductive gel paste. Its categories also span medical devices, consumer electronics, mental health, and wellness, reflecting a hybrid positioning rather than a clearly established clinical-device or purely lifestyle brand.

Hoolest was founded in 2018 and has one disclosed financing-related milestone: $100,000 in ASU Innovation Open prize money that year. No later funding rounds, valuation, hiring announcements, or workforce changes are identified. The company’s reported employee range is one to ten, consistent with a small operation, although this is not a time series and does not establish whether headcount has grown. The product portfolio indicates development beyond the original VeRelief concept: it now includes the VeRelief Prime handheld stimulator, Hoolest Pro stimulation headphones, Mini-Max PEMF, and Hoolest Sleep. The most visible strategic direction is expansion from portable, on-demand vagus nerve stimulation into complementary audio, electromagnetic stimulation, and supplement offerings. Overall, Hoolest shows product-line breadth but limited disclosed evidence of funding or organizational scale-up; further dated milestones would be needed to assess its growth rate or commercial traction.